Antiapoptotic properties of erythropoietin: Novel strategies for protection of retinal pigment epithelial cells

Eye

Volumn 23, Issue 12, 2009, Pages 2245-2250

  Gawad, A E ^a,b   Schlichting, L ^a   Strau, O ^a,c   Zeitz, O ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b RESEARCH INSTITUTE OF OPHTHALMOLOGY   (Egypt)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Age related macula degeneration; Erythropoietin; Free radicals; Oxidative stress; Retinal pigment epithelium

Indexed keywords

DNA NUCLEOTIDYLEXOTRANSFERASE; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; HYDROGEN PEROXIDE; LIPOCORTIN 5;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PIGMENT EPITHELIUM; PROTEIN EXPRESSION; PROTEIN FUNCTION;

APOPTOSIS; BLOTTING, WESTERN; CELLS, CULTURED; ERYTHROPOIETIN; HUMANS; HYDROXYL RADICAL; MACULAR DEGENERATION; OXIDATIVE STRESS; RECEPTORS, ERYTHROPOIETIN; RETINAL PIGMENT EPITHELIUM;

EID: 72749122032     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.398     Document Type: Article

References (24)

1. Strauss O. The retinal pigment epithelium in visual function. Physiol Rev 2005; 85(3): 845-881.
2. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000; 45(2): 115-134.
3. Sparrow JR, Zhou J, Ben-Shabat S, Vollmer H, Itagaki Y, Nakanishi K. Involvement of oxidative mechanisms in bluelight- induced damage to A2E-laden RPE. Invest Ophthalmol Vis Sci 2002; 43(4): 1222-1227.
4. Rozanowska M, Jarvis-Evans J, Korytowski W, Boulton ME, Burke JM, Sarna T. Blue light-induced reactivity of retinal age pigment. In vitro generation of oxygen-reactive species. J Biol Chem 1995; 270(32): 18825-18830.
5. Rozanowska M, Wessels J, Boulton M, Burke JM, Rodgers MA, Truscott TG et al. Blue light-induced singlet oxygen generation by retinal lipofuscin in non-polar media. Free Radic Biol Med 1998; 24(7-8): 1107-1112.
6. The AREDS Investigator Group. A randomized, placebocontrolled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001; 119(10): 1417-1436.
7. Marti HH. Erythropoietin and the hypoxic brain. J Exp Biol 2004; 207(Part 18): 3233-3242.
8. Grimm C, Wenzel A, Groszer M, Mayser H, Seeliger M, Samardzija M et al. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 2002; 8(7): 718-724.
9. Weishaupt JH, Rohde G, Pölking E, Siren AL, Ehrenreich H, Bähr M. Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci 2004; 45(5): 1514-1522.
10. Junk AK, Mammis A, Savitz SI, Singh M, Roth S, Malhotra S et al. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci USA 2002; 99(16): 10659-10664.
11. Zeitz O, Schlichting L, Richard G, Strauss O. Lack of antioxidative properties of vitamin C and pyruvate in cultured retinal pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol 2007; 245(2): 276-281.
12. Zweier JL, Thompson-Gorman S, Kuppusamy P. Measurement of oxygen concentrations in the intact beating heart using electron paramagnetic resonance spectroscopy: a technique for measuring oxygen concentrations in situ. J Bioener Biomembr 1991; 23(6): 855-871.
13. Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci USA 2005; 102(38): 13604-13609.
14. Ihle JN. Cytokine receptor signalling. Nature 1995; 377(6550): 591-594.
15. Siren AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 2001; 98(7): 4044-4049.
16. Silva M, Benito A, Sanz C, Prosper F, Ekhterae D, Nuñez G et al. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines. J Biol Chem 1999; 274(32): 22165-22169.
17. Meng Y, Niu YJ, Qu H. [The research of the protection of recombinant human erythropoietin in human RPE cells by light-induced injuries]. Zhonghua Yan Ke Za Zhi 2008; 44(1): 50-55.
18. Cohen J, Oren-Young L, Klingmuller U, Neumann D. Protein tyrosine phosphatase 1B participates in the down-regulation of erythropoietin receptor signalling. Biochem J 2004; 377(Part 2): 517-524.
19. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med (Cambridge, Mass) 2002; 8(8): 495-505.
20. Ehrenreich H, Hinze-Selch D, Stawicki S, Aust C, Knolle-Veentjer S, Wilms S et al. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry 2007; 12(2): 206-220.
21. Watanabe D, Suzuma K, Matsui S, Kurimoto M, Kiryu J, Kita M et al. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 2005; 353(8): 782-792. (Pubitemid 41215487)
22. Jaquet K, Krause K, Tawakol-Khodai M, Geidel S, Kuck KH. Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res 2002; 64(2): 326-333.
23. Song BJ, Cai H, Tsai JC, Chang S, Forbes M, Del Priore LV. Intravitreal recombinant human erythropoietin: a safety study in rabbits. Curr Eye Res 2008; 33(9): 750-760.
24. Zhang J,Wu Y, Jin Y, Ji F, Sinclair SH, Luo Yet al. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest Ophthalmol Vis Sci 2008; 49(2): 732-742.